Tang Capital Management as of Sept. 30, 2023
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 106 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals (TARS) | 5.4 | $38M | 2.1M | 17.77 | |
| Mirum Pharmaceuticals (MIRM) | 5.1 | $36M | 1.1M | 31.60 | |
| Anaptysbio Inc Common (ANAB) | 4.9 | $35M | 2.0M | 17.96 | |
| Kalvista Pharmaceuticals (KALV) | 4.7 | $33M | 3.4M | 9.63 | |
| Evolus (EOLS) | 4.0 | $28M | 3.1M | 9.14 | |
| ImmunoGen | 3.4 | $24M | 1.5M | 15.87 | |
| Eqrx | 3.2 | $22M | 10M | 2.22 | |
| Axsome Therapeutics (AXSM) | 3.2 | $22M | 320k | 69.89 | |
| Immunocore Hldgs Ads (IMCR) | 3.0 | $21M | 406k | 51.90 | |
| New York Community Ban | 2.6 | $18M | 1.6M | 11.34 | |
| Eli Lilly & Co. (LLY) | 2.3 | $16M | 30k | 537.13 | |
| Intra Cellular Therapies (ITCI) | 2.2 | $16M | 300k | 52.09 | |
| Vaxcyte (PCVX) | 2.2 | $15M | 300k | 50.98 | |
| Beigene Sponsored Adr | 2.2 | $15M | 85k | 179.87 | |
| Bluebird Bio (BLUE) | 1.8 | $13M | 4.3M | 3.04 | |
| BioCryst Pharmaceuticals (BCRX) | 1.8 | $13M | 1.8M | 7.08 | |
| Intellia Therapeutics (NTLA) | 1.8 | $13M | 398k | 31.62 | |
| Astrazeneca Sponsored Adr (AZN) | 1.6 | $12M | 170k | 67.72 | |
| Third Harmonic Bio (THRD) | 1.6 | $12M | 1.8M | 6.39 | |
| Atea Pharmaceuticals (AVIR) | 1.5 | $11M | 3.6M | 3.00 | |
| Kiniksa Pharmaceuticals Com Cl A | 1.5 | $10M | 600k | 17.37 | |
| Avadel Pharmaceuticals Sponsored Adr | 1.5 | $10M | 1.0M | 10.30 | |
| Miragen Therapeutics (VRDN) | 1.4 | $10M | 669k | 15.34 | |
| Ionis Pharmaceuticals (IONS) | 1.3 | $9.1M | 200k | 45.36 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.3 | $8.9M | 271k | 32.77 | |
| Bio Rad Labs Cl A (BIO) | 1.2 | $8.6M | 24k | 358.45 | |
| Inflarx Nv (IFRX) | 1.2 | $8.4M | 2.8M | 2.98 | |
| Cytomx Therapeutics (CTMX) | 1.2 | $8.3M | 6.5M | 1.29 | |
| Dianthus Therapeutics (DNTH) | 1.1 | $8.1M | 592k | 13.67 | |
| Novocure Ord Shs (NVCR) | 1.1 | $7.9M | 492k | 16.15 | |
| Moderna (MRNA) | 1.1 | $7.9M | 77k | 103.29 | |
| Mirati Therapeutics | 1.1 | $7.8M | 180k | 43.56 | |
| Verastem Com New (VSTM) | 1.0 | $7.2M | 892k | 8.13 | |
| Altimmune Com New (ALT) | 1.0 | $7.2M | 2.8M | 2.60 | |
| Zymeworks Del (ZYME) | 1.0 | $7.0M | 1.1M | 6.34 | |
| Bioatla (BCAB) | 0.9 | $6.4M | 3.8M | 1.70 | |
| Uniqure Nv SHS (QURE) | 0.9 | $6.3M | 936k | 6.71 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $5.8M | 750k | 7.77 | |
| Cullinan Oncology (CGEM) | 0.8 | $5.6M | 621k | 9.05 | |
| Equity Comwlth Com Sh Ben Int (EQC) | 0.8 | $5.5M | 300k | 18.37 | |
| Avrobio Ord (AVRO) | 0.8 | $5.4M | 3.5M | 1.54 | |
| Amarin Corp Spons Adr New (AMRN) | 0.8 | $5.4M | 5.9M | 0.92 | |
| Graphite Bio | 0.7 | $5.0M | 2.0M | 2.48 | |
| Adma Biologics (ADMA) | 0.7 | $4.9M | 1.4M | 3.58 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.6 | $4.4M | 300k | 14.77 | |
| Insmed Com Par $.01 (INSM) | 0.6 | $4.2M | 166k | 25.25 | |
| Citigroup Com New (C) | 0.6 | $4.1M | 100k | 41.13 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.6 | $4.0M | 5.2M | 0.78 | |
| Cortexyme (QNCX) | 0.6 | $3.9M | 3.5M | 1.12 | |
| Veritex Hldgs (VBTX) | 0.5 | $3.8M | 210k | 17.95 | |
| Bolt Biotherapeutics (BOLT) | 0.5 | $3.7M | 3.6M | 1.04 | |
| Biohaven (BHVN) | 0.5 | $3.6M | 140k | 26.01 | |
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.5 | $3.6M | 1.9M | 1.88 | |
| Genfit S A Ads (GNFT) | 0.5 | $3.4M | 1.0M | 3.27 | |
| CVB Financial (CVBF) | 0.5 | $3.3M | 200k | 16.57 | |
| Us Bancorp Del Com New (USB) | 0.5 | $3.3M | 100k | 33.06 | |
| Rain Therapeutics | 0.5 | $3.2M | 3.7M | 0.86 | |
| Design Therapeutics (DSGN) | 0.4 | $3.2M | 1.4M | 2.36 | |
| Galapagos Nv Spon Adr (GLPG) | 0.4 | $3.1M | 90k | 34.55 | |
| Enzo Biochem (ENZ) | 0.4 | $3.1M | 2.2M | 1.40 | |
| Rocket Pharmaceuticals (RCKT) | 0.4 | $3.1M | 150k | 20.49 | |
| Cymabay Therapeutics | 0.4 | $3.0M | 200k | 14.91 | |
| Lianbio Sponsored Ads (LIANY) | 0.4 | $2.7M | 1.8M | 1.49 | |
| Elevation Oncology (ELEV) | 0.4 | $2.7M | 4.0M | 0.66 | |
| Aligos Therapeutics | 0.4 | $2.5M | 3.3M | 0.75 | |
| Nektar Therapeutics (NKTR) | 0.3 | $2.3M | 3.9M | 0.60 | |
| Mei Pharma (MEIP) | 0.3 | $2.3M | 326k | 7.01 | |
| Tango Therapeutics (TNGX) | 0.3 | $2.3M | 200k | 11.26 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $2.1M | 100k | 20.84 | |
| Pds Biotechnology Ord (PDSB) | 0.3 | $2.0M | 400k | 5.05 | |
| Heron Therapeutics (HRTX) | 0.3 | $1.9M | 1.9M | 1.03 | |
| Bionomics Ads | 0.3 | $1.9M | 700k | 2.70 | |
| Eagle Pharmaceuticals (EGRX) | 0.3 | $1.9M | 119k | 15.77 | |
| Esperion Therapeutics (ESPR) | 0.3 | $1.8M | 1.9M | 0.98 | |
| Karuna Therapeutics Ord | 0.2 | $1.7M | 10k | 169.09 | |
| Adicet Bio (ACET) | 0.2 | $1.7M | 1.2M | 1.37 | |
| Journey Med Corp (DERM) | 0.2 | $1.6M | 576k | 2.74 | |
| Arvinas Ord (ARVN) | 0.2 | $1.6M | 80k | 19.64 | |
| Servisfirst Bancshares (SFBS) | 0.2 | $1.6M | 30k | 52.17 | |
| Editas Medicine (EDIT) | 0.2 | $1.6M | 200k | 7.80 | |
| Silverback Therapeutics (SPRY) | 0.2 | $1.5M | 410k | 3.78 | |
| Nkarta (NKTX) | 0.2 | $1.5M | 1.1M | 1.39 | |
| Coherus Biosciences (CHRS) | 0.2 | $1.5M | 400k | 3.74 | |
| Bank of Hawaii Corporation (BOH) | 0.2 | $1.5M | 30k | 49.69 | |
| Fate Therapeutics (FATE) | 0.2 | $1.5M | 700k | 2.12 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $1.1M | 400k | 2.87 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.1 | $936k | 10k | 93.64 | |
| Tg Therapeutics (TGTX) | 0.1 | $836k | 100k | 8.36 | |
| Atyr Pharma Com New (ATYR) | 0.1 | $744k | 471k | 1.58 | |
| Athira Pharma (ATHA) | 0.1 | $713k | 353k | 2.02 | |
| Gossamer Bio (GOSS) | 0.1 | $698k | 839k | 0.83 | |
| 908 Devices (MASS) | 0.1 | $666k | 100k | 6.66 | |
| Adagio Therapeutics (IVVD) | 0.1 | $623k | 367k | 1.70 | |
| Inspirato Incorporated Com Cl A | 0.1 | $517k | 876k | 0.59 | |
| Nextcure (NXTC) | 0.1 | $516k | 400k | 1.29 | |
| Gracell Biotechnologies Sponsored Ads | 0.1 | $458k | 159k | 2.88 | |
| Stellar Bancorp Ord (STEL) | 0.1 | $426k | 20k | 21.32 | |
| Selecta Biosciences | 0.1 | $424k | 400k | 1.06 | |
| Molecular Partners Ads (MOLN) | 0.1 | $414k | 100k | 4.14 | |
| Equillium (EQ) | 0.0 | $296k | 400k | 0.74 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $279k | 150k | 1.86 | |
| Neuronetics (STIM) | 0.0 | $270k | 200k | 1.35 | |
| Passage Bio (PASG) | 0.0 | $263k | 400k | 0.66 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $232k | 64k | 3.64 | |
| Acelrx Pharmaceuticals Com New (TLPH) | 0.0 | $113k | 195k | 0.58 | |
| Transcode Therapeutics Com New | 0.0 | $42k | 84k | 0.50 |
